Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval
The Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MoreThe Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MorePfizer’s shot is the one one licensed in the US for kids below the age of 18 (Report) Washington: US
Read MoreHow did you get into the vaccine industry? Once I started conceptualising a Hepatitis vaccine, I used to be operating
Read MoreThe Drug Controller Common of India (DCGI) on Sunday authorized the emergency use of each Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin
Read MoreBharat Biotech had mentioned that it plans to hide 28,500 topics in its Section three trial. New Delhi: Covaxin, the
Read More